Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis

So Imakiire(Fukuoka University), Fumihito Hirai(Fukuoka University), Hideki Ishibashi(Fukuoka University), Hideto Sakisaka(Fukuoka University), Keiichi Mitsuyama(Kurume University), Hidetoshi Takedatsu(Kurume University), Koichi Abe(Iwate Medical University), Nobuaki Kuno(Fukuoka University), Kozo Tsuruta(Kurume University), Shinichiro Yoshioka(Kurume University), Takuji Torimura(Omuta hospital), Masaru Morita(Kurume University), Sadahiro Funakoshi(Fukuoka University)
Gut and Liver
January 14, 2022
10.5009/gnl210211
Cited by 23

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410